IL79700A - Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine or phosphates thereof and their use in a method for alleviating the cytopathic effects of htlv-iii virus on cells in vitro - Google Patents

Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine or phosphates thereof and their use in a method for alleviating the cytopathic effects of htlv-iii virus on cells in vitro

Info

Publication number
IL79700A
IL79700A IL79700A IL7970086A IL79700A IL 79700 A IL79700 A IL 79700A IL 79700 A IL79700 A IL 79700A IL 7970086 A IL7970086 A IL 7970086A IL 79700 A IL79700 A IL 79700A
Authority
IL
Israel
Prior art keywords
dideoxyguanosine
dideoxyadenosine
dideoxyinosine
htlv
alleviating
Prior art date
Application number
IL79700A
Other languages
English (en)
Other versions
IL79700A0 (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25084165&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL79700(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL79700A0 publication Critical patent/IL79700A0/xx
Publication of IL79700A publication Critical patent/IL79700A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
IL79700A 1985-08-26 1986-08-12 Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine or phosphates thereof and their use in a method for alleviating the cytopathic effects of htlv-iii virus on cells in vitro IL79700A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76901685A 1985-08-26 1985-08-26

Publications (2)

Publication Number Publication Date
IL79700A0 IL79700A0 (en) 1986-11-30
IL79700A true IL79700A (en) 1991-09-16

Family

ID=25084165

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79700A IL79700A (en) 1985-08-26 1986-08-12 Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine or phosphates thereof and their use in a method for alleviating the cytopathic effects of htlv-iii virus on cells in vitro

Country Status (16)

Country Link
US (1) US4861759A (fr)
EP (1) EP0216510B1 (fr)
JP (1) JPS62501712A (fr)
AT (1) ATE96325T1 (fr)
AU (1) AU570853B2 (fr)
CA (1) CA1269044A (fr)
CY (1) CY1792A (fr)
DE (1) DE3689220T2 (fr)
HK (1) HK47694A (fr)
IE (1) IE64518B1 (fr)
IL (1) IL79700A (fr)
LU (1) LU88475I2 (fr)
MX (1) MX9203377A (fr)
NL (1) NL940005I2 (fr)
NZ (1) NZ217185A (fr)
WO (1) WO1987001284A1 (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5446029A (en) * 1986-07-04 1995-08-29 Medivir Ab Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5495010A (en) * 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
US5166140A (en) * 1987-05-05 1992-11-24 City Of Hope Use of certain nucleoside analogs to attenuate cancer cell resistance to DNA damaging chemotherapy
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
EP0374096B1 (fr) * 1988-12-14 1992-12-02 Ciba-Geigy Ag Thérapie combinée utilisant le 2',5'-didéoxypurine nucléoside et inhibiteur de purine nucléoside-phosphorylase et ses compositions
IL93682A (en) * 1989-03-16 1996-06-18 Yeda Res & Dev Polycyclic compounds with antigypical activity are used in the manufacture of medicines and pharmaceutical preparations containing them
GR1000618B (el) * 1989-03-17 1992-08-31 Oncogen Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.
US5013829A (en) * 1989-04-26 1991-05-07 University Of Iowa Research Foundation Stable congener of 2',3'-dideoxyadenosine
US5571839A (en) * 1989-04-28 1996-11-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors
US6207650B1 (en) * 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
EP0472663A4 (en) * 1989-05-15 1992-07-01 Us Commerce Method of treatment of hepatitis
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
US5268389A (en) * 1989-10-16 1993-12-07 Uniroyal Chemical Company, Inc. Thiocarboxylate ester compounds compositions containing the same
US5026687A (en) * 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
US5914331A (en) * 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US6703396B1 (en) 1990-02-01 2004-03-09 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5925643A (en) * 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
US5221611A (en) * 1991-06-19 1993-06-22 Sigma Chemical Company Ddi immunoassays, derivatives, conjugates and antibodies
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5231174A (en) * 1992-02-27 1993-07-27 University Of Iowa Research Foundation 2'isodideoxy-β-D-nucleosides as stable antiviral agents
US6429208B1 (en) * 1992-03-27 2002-08-06 Regents Of The University Of California Methods and compositions for restoring impaired cellular immune function
US20050192299A1 (en) * 1992-04-16 2005-09-01 Yung-Chi Cheng Method of treating or preventing hepatitis B virus
US6046175A (en) * 1993-05-21 2000-04-04 The United States Of America As Represented By The Department Of Health And Human Services Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
WO1995007086A1 (fr) * 1993-09-10 1995-03-16 Emory University Nucleosides a activite contre le virus de l'hepatite b
US20020120130A1 (en) * 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
US5521161A (en) * 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide
WO1995017875A2 (fr) * 1993-12-20 1995-07-06 Compagnie De Developpement Aguettant MELANGES DE DIDESOXY-NUCLEOSIDES ET DE β-HYDROXAMATE DE L'ACIDE D-ASPARTIQUE UTILISE DANS L'INHIBITION DE LA PROPAGATION D'UN RETROVIRUS
US6093702A (en) * 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
DK0831852T3 (da) * 1995-06-07 2007-03-19 Univ Emory Nukleosider med anti-hepatitis B-virusaktivitet
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
CA2189097A1 (fr) 1995-11-15 1997-05-16 Pin-Fang Lin Composition et methode pour le traitement de l'infection retrovirale
US5728560A (en) * 1996-06-14 1998-03-17 Enzon, Inc. Method of treating CD4+ T cell lymphopenia in immuno-compromised patients
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
US6369237B1 (en) 1997-03-07 2002-04-09 President And Fellows Of Harvard College DNA glycosylase inhibitors, and uses related thereto
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
JP2000136136A (ja) * 1998-10-30 2000-05-16 Fujirebio Inc 抗ウイルス剤
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
CA2270600A1 (fr) 1999-05-03 2000-11-03 Infectio Recherche Inc. Methode et preparations pour le traitement de maladies, en particulier de celles causees par le virus de l'immunodeficience humaine et leishmania
RU2158592C1 (ru) * 1999-12-29 2000-11-10 Каплина Элли Николаевна Противовирусное иммунотропное средство
US6436948B1 (en) 2000-03-03 2002-08-20 University Of Georgia Research Foundation Inc. Method for the treatment of psoriasis and genital warts
RU2172632C1 (ru) * 2000-12-01 2001-08-27 Каплина Элли Николаевна Способ получения иммунотропного противовирусного препарата
RU2188659C1 (ru) * 2001-04-20 2002-09-10 ООО Научно-производственное фармацевтическое предприятие "Полидан" Фармацевтическая композиция для терапии человека, обладающая иммунотропным действием
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
PL216369B1 (pl) 2004-07-27 2014-03-31 Gilead Sciences Pochodne fosfonianowe, kompozycje farmaceutyczne zawierające te pochodne oraz zastosowanie tych pochodnych do wytwarzania leku do hamowania wirusa HIV
WO2010077613A1 (fr) 2008-12-09 2010-07-08 Gilead Sciences, Inc. Modulateurs de récepteurs de type toll (tlr)
US20110223131A1 (en) 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
WO2016001907A1 (fr) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv et mogroside v utilisables en tant qu'agonistes/stimulateurs/agents de déblocage des récepteurs toll 4 et adjuvant destiné à être utilisé dans un vaccin humain/animal et pour stimuler l'immunité contre des agents pathologiques
EP4140485A1 (fr) 2014-07-11 2023-03-01 Gilead Sciences, Inc. Modulateurs de récepteurs de type toll pour le traitement du vih
HK1257270A1 (zh) 2015-09-15 2019-10-18 Gilead Sciences, Inc. 用於治療hiv的toll樣受體(tlr)調節劑
CA3087932A1 (fr) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Composes acetal et leurs utilisations therapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4112221A (en) * 1974-07-17 1978-09-05 Asahi Kasei Kogyo Kabushiki Kaisha Process for preparing 8,2'-O-anhydropurine nucleosides
JPS5735516A (en) * 1980-08-11 1982-02-26 Yamasa Shoyu Co Ltd Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JPS59104399A (ja) * 1982-12-03 1984-06-16 Takeda Chem Ind Ltd ヌクレオチドおよびヌクレオシドの相互分離方法
NZ216172A (en) * 1985-05-15 1989-08-29 Wellcome Found Nucleosides and pharmaceutical compositions

Also Published As

Publication number Publication date
NL940005I2 (nl) 1999-08-02
IE940570L (en) 1987-02-26
EP0216510B1 (fr) 1993-10-27
DE3689220D1 (de) 1993-12-02
LU88475I2 (fr) 1994-09-09
AU6196886A (en) 1987-03-24
EP0216510A3 (en) 1989-08-02
DE3689220T2 (de) 1994-02-24
ATE96325T1 (de) 1993-11-15
JPS62501712A (ja) 1987-07-09
NL940005I1 (nl) 1994-05-16
JPH0215523B2 (fr) 1990-04-12
WO1987001284A1 (fr) 1987-03-12
HK47694A (en) 1994-05-20
CA1269044A (fr) 1990-05-15
IE64518B1 (en) 1995-08-09
IL79700A0 (en) 1986-11-30
US4861759A (en) 1989-08-29
MX9203377A (es) 1992-09-01
EP0216510A2 (fr) 1987-04-01
NZ217185A (en) 1990-03-27
AU570853B2 (en) 1988-03-24
IE862265L (en) 1987-02-26
CY1792A (en) 1995-10-20

Similar Documents

Publication Publication Date Title
IL79700A (en) Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine or phosphates thereof and their use in a method for alleviating the cytopathic effects of htlv-iii virus on cells in vitro
AU1096183A (en) Antiviral purines
EP0502105A4 (en) Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
AU2954989A (en) Improvements in or relating to energy absorbers
IL79699A0 (en) Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate
DE3473272D1 (en) Guanine derivatives, compositions containing them, and their anti-viral use
AU587059B2 (en) Epoxy fluorocarbon coating compositions and the process to make same
DK206286D0 (da) Fremgangsmaade til fremstilling af zeolit-holdige partikler samt fremgangsmaade til omdannelse af carbonhydrider
AU6305486A (en) 2-aminopurines substituted in the 6- and 9-position, their use, medicaments containing these purines, and processes for the preparation of the purines
MY102460A (en) Antiviral agent .
DE3160159D1 (en) Light collector systems and the use of coumarin derivatives as energy converters in such systems
GB2188292B (en) Vehicles modified to accomodate wheel chairs
ES8605520A1 (es) Procedimiento para la preparacion de 1,3-bis-esteres fosfatoy esteres fosfato ciclico de 9-1,3-dihidroxi-2-propoximetil-guanina
SG32294G (en) Inhibition of in vitro infecivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine
NO964009D0 (no) Fremgangsmåte for fremstilling av (1H-tetrazol-5-yl)tetra-zolo[1,5-aÅkinoliner og nafthyridiner
PT83116A (en) Process for the preparation of 5-chloro-s-triazolo <4,3-a> pyridine-7-carboxylic acids
MY101451A (en) Crystalline form of 7-(dimethylaminothylene) amino-9a-methoxymitosane
ZA837287B (en) 1-monophosphate esters,1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents
GB2175545B (en) Child's perambulator of the foldable push-chair type
ZA867229B (en) 2-aminopurines substituted in the 6-and 9-position,their use,medicaments containing these purines,and processes for the preparation of the purines
GR80347B (en) Baby's high chair with wheels
AU4121985A (en) Antiviral purine derivatives
AU94180S (en) Child's table
ES286854Y (es) Dispositivo para la inclinacion de respaldos en cochecitos infantiles
FI921177L (fi) Menetelmä 9-(1,3-dihydroksi-2-propoksimetyyli)-guaniinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired